Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Observations

Use of Highly Purified Synthetic Calcium Sulfate Impregnated With Antibiotics for the Management of Diabetic Foot Ulcers Complicated by Osteomyelitis

  1. Rajesh M. Jogia1,
  2. Deborah E. Modha2,
  3. Kaustubh Nisal1,
  4. Rachel Berrington1 and
  5. Marie-France Kong1⇑
  1. 1Department of Diabetes, University Hospitals of Leicester NHS Trust, Leicester, U.K.
  2. 2Department of Microbiology, University Hospitals of Leicester NHS Trust, Leicester, U.K.
  1. Corresponding author: Marie-France Kong, marie-france.kong{at}uhl-tr.nhs.uk.
Diabetes Care 2015 May; 38(5): e79-e80. https://doi.org/10.2337/dc14-3100
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Diabetic foot osteomyelitis can be managed medically with systemic antibiotics alone or surgically by removing infected bone (1,2). Localized delivery of antibiotics directly to the bone offers a way to achieve an optimal concentration of chosen antibiotics at the site of infection. Antibiotics have been delivered directly into wounds using various vehicles, such as methyl methacrylate and absorbable antibiotic-impregnated gauze, in other clinical settings (3). Highly purified synthetic (HPS) calcium sulfate–based antibiotic therapy offers advantages of being biodegradable, having predictable elution characteristics to deliver antibiotics in concentrations far exceeding the minimum inhibitory concentration of the infecting organism, and having an ability to fill dead space (4,5). We report our experience of using HPS calcium sulfate impregnated with vancomycin and gentamicin in the management of osteomyelitis in the diabetic forefoot.

Over 18 months, 20 patients (15 males) with diabetic foot ulcers attending our multidisciplinary foot clinic were treated with minimal surgical intervention and local delivery of vancomycin and gentamicin using HPS calcium sulfate. The median age was 59 years (range 25–74). Mean HbA1c was 8.4% (68 mmol/mol) (range 6.5–11% [48–97 mmol/mol]). All patients had forefoot ulcers with underlying osteomyelitis (all confirmed radiologically and 11 had earlier bone samples confirming osteomyelitis) and had failed to respond to regular wound debridement, systemic antibiotics, and off-loading. Eighteen patients had no evidence of peripheral vascular disease. Median ulcer duration prior to intervention was 11.5 weeks (range 3.6–104). Vancomycin and gentamicin were selected as the antibiotics of choice based on in vitro sensitivities of isolates obtained from diabetic foot infections in our laboratory. All surgical procedures were carried out by the same individual. HPS calcium sulfate powder was mixed with 1 g of vancomycin hydrochloride and 80 mg of gentamicin sulfate to form pellets. Sequestrae were excised, the bone was fenestrated and packed with the pellets, and primary closure was carried out. The ulcer was defined as fully healed when epithelization was complete and the intervention was considered successful when there was no reoccurrence for 12 months.

Intraoperative bone samples showed all the gram-positive isolates were sensitive to vancomycin. All but two gram-negative isolates were sensitive to gentamicin. Two patients grew Candida species in addition to their bacterial isolate and received an oral antifungal agent postoperatively. The need for postoperative antibiotics was decided individually as per clinical assessment and the median duration was 2 weeks (range 0–9). All patients achieved healing with a median time span of 5 weeks and no recurrence within 12 months after intervention (Fig. 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Foot X-ray of one of the patients 16 months postoperatively.

We have found this technique to be safe and effective for the treatment of forefoot diabetic osteomyelitis and believe that this has prevented more radical surgery. No adverse reactions were noted in these patients or indeed in any of our additional patients over the past 36 months. We now also offer this treatment to patients with midfoot and calcaneal osteomyelitis.

We acknowledge limitations of our case series given the small number of patients and suggest a randomized controlled trial to further evaluate this technique.

Article Information

Acknowledgments. The authors thank Professor William Jeffcoate (Foot Ulcer Trials Unit, Nottingham University Hospitals Trust, U.K.) for his helpful comments and time spent reviewing the manuscript.

Duality of Interest. D.E.M. received sponsorship from Biocomposites, the manufacturer of Stimulan (purified synthetic calcium sulfate), to attend a microbiology and infectious disease conference. No other potential conflicts of interest relevant to this article were reported.

Author Contributions. R.M.J. wrote the manuscript. D.E.M. researched data and reviewed and edited the manuscript. K.N. and M.-F.K. reviewed and edited the manuscript. R.B. researched data and reviewed the manuscript. D.E.M. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

  • © 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

References

  1. ↵
    1. Game FL,
    2. Jeffcoate WJ
    . Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008;51:962–967
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Aragón-Sánchez FJ,
    2. Cabrera-Galván JJ,
    3. Quintana-Marrero Y, et al
    . Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement. Diabetologia 2008;51:1962–1970
    OpenUrlCrossRefPubMed
  3. ↵
    1. Gogia JS,
    2. Meehan JP,
    3. Di Cesare PE,
    4. Jamali AA
    . Local antibiotic therapy in osteomyelitis. Semin Plast Surg 2009;23:100–107
    OpenUrlCrossRefPubMed
  4. ↵
    1. Bistolfi A,
    2. Massazza G,
    3. Vernè E, et al
    . Antibiotic-loaded cement in orthopedic surgery: a review. ISRN Ortho 2011;2011290851
  5. ↵
    1. Gauland C
    . Managing lower-extremity osteomyelitis locally with surgical debridement and synthetic calcium sulfate antibiotic tablets. Adv Skin Wound Care 2011;24:515–523
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Diabetes Care: 38 (5)

In this Issue

May 2015, 38(5)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of Highly Purified Synthetic Calcium Sulfate Impregnated With Antibiotics for the Management of Diabetic Foot Ulcers Complicated by Osteomyelitis
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of Highly Purified Synthetic Calcium Sulfate Impregnated With Antibiotics for the Management of Diabetic Foot Ulcers Complicated by Osteomyelitis
Rajesh M. Jogia, Deborah E. Modha, Kaustubh Nisal, Rachel Berrington, Marie-France Kong
Diabetes Care May 2015, 38 (5) e79-e80; DOI: 10.2337/dc14-3100

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Use of Highly Purified Synthetic Calcium Sulfate Impregnated With Antibiotics for the Management of Diabetic Foot Ulcers Complicated by Osteomyelitis
Rajesh M. Jogia, Deborah E. Modha, Kaustubh Nisal, Rachel Berrington, Marie-France Kong
Diabetes Care May 2015, 38 (5) e79-e80; DOI: 10.2337/dc14-3100
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • DPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
  • Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
  • Comparison of Diagnostic Accuracy for Lower-Extremity Amputation Codes During the ICD-9 and ICD-10 Eras in a High-Risk Population of Patients With Diabetes
Show more e-Letters: Observations

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.